FDA Inspection
Kesin PharmaKesin Pharma – FDA Inspection, Jan 19, 2024
Record Details
This FDA Inspection record concerns Kesin Pharma, with an inspection on January 19, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e721e73a-5c98-47c0-be49-6d7f7fec701a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227332
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.84(d)(2)Component written specification
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.